Aurora Cannabis (ACB) Receivables - Other (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Receivables - Other data on file, last reported at -$396548.7 in Q4 2025.

• Receivables - Other for Q4 2025 came in at -$396548.7, up 78.94% year-over-year; the trailing twelve-month figure through Dec 2025 was -$396548.7 (up 78.94% YoY), and the FY2025 annual result was $3.7 million, up 449.65% from the prior year.
• Receivables - Other eased to -$396548.7 in Q4 2025 per ACB's latest filing, from $3.3 million in the prior quarter.
• Over five years, Receivables - Other peaked at $611.7 million in Q1 2021 and troughed at -$2.3 million in Q3 2022.
• A 5-year average of $30.7 million and a median of -$181179.0 in 2021 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other sank 1550.29% in 2022, then surged 513.05% in 2023.
• A 5-year view of Receivables - Other shows it stood at -$202300.7 in 2021, then sank by 859.57% to -$1.9 million in 2022, then surged by 83.99% to -$310708.5 in 2023, then plunged by 505.93% to -$1.9 million in 2024, then surged by 78.94% to -$396548.7 in 2025.
• Business Quant data shows ACB's Receivables - Other at -$396548.7 in Q4 2025, $3.3 million in Q3 2025, and $75779.8 in Q2 2025.